Precision BioSciences Statistics
Total Valuation
DTIL has a market cap or net worth of $59.97 million. The enterprise value is -$10.93 million.
Important Dates
The last earnings date was Monday, November 4, 2024, before market open.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DTIL has 7.23 million shares outstanding. The number of shares has increased by 98.69% in one year.
| Shares Outstanding | 7.23M |
| Shares Change (YoY) | +98.69% |
| Shares Change (QoQ) | +6.69% |
| Owned by Insiders (%) | 2.32% |
| Owned by Institutions (%) | 33.14% |
| Float | 5.84M |
Valuation Ratios
The trailing PE ratio is 5.40.
| PE Ratio | 5.40 |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| Forward PS | 1.60 |
| PB Ratio | 0.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.22, with a Debt / Equity ratio of 0.47.
| Current Ratio | 9.22 |
| Quick Ratio | 8.58 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.23 |
Financial Efficiency
Return on equity (ROE) is 24.44% and return on invested capital (ROIC) is -13.68%.
| Return on Equity (ROE) | 24.44% |
| Return on Assets (ROA) | -6.38% |
| Return on Capital (ROIC) | -13.68% |
| Revenue Per Employee | $688,954 |
| Profits Per Employee | $79,110 |
| Employee Count | 109 |
| Asset Turnover | 0.47 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.07% in the last 52 weeks. The beta is 1.69, so DTIL's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -35.07% |
| 50-Day Moving Average | 9.34 |
| 200-Day Moving Average | 10.85 |
| Relative Strength Index (RSI) | 40.39 |
| Average Volume (20 Days) | 89,358 |
Short Selling Information
The latest short interest is 214,461, so 2.96% of the outstanding shares have been sold short.
| Short Interest | 214,461 |
| Short Previous Month | 217,567 |
| Short % of Shares Out | 2.96% |
| Short % of Float | 3.67% |
| Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, DTIL had revenue of $75.10 million and earned $8.62 million in profits. Earnings per share was $1.15.
| Revenue | 75.10M |
| Gross Profit | 75.10M |
| Operating Income | -16.21M |
| Pretax Income | 16.97M |
| Net Income | 8.62M |
| EBITDA | -11.98M |
| EBIT | -16.21M |
| Earnings Per Share (EPS) | $1.15 |
Full Income StatementBalance Sheet
The company has $101.20 million in cash and $30.31 million in debt, giving a net cash position of $70.90 million or $9.80 per share.
| Cash & Cash Equivalents | 101.20M |
| Total Debt | 30.31M |
| Net Cash | 70.90M |
| Net Cash Per Share | $9.80 |
| Equity (Book Value) | 64.87M |
| Book Value Per Share | 8.67 |
| Working Capital | 98.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$48.19 million and capital expenditures -$127,000, giving a free cash flow of -$48.31 million.
| Operating Cash Flow | -48.19M |
| Capital Expenditures | -127,000 |
| Free Cash Flow | -48.31M |
| FCF Per Share | -$6.68 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -21.58% and 11.48%.
| Gross Margin | 100.00% |
| Operating Margin | -21.58% |
| Pretax Margin | 15.28% |
| Profit Margin | 11.48% |
| EBITDA Margin | -15.95% |
| EBIT Margin | -21.58% |
| FCF Margin | -75.01% |
Dividends & Yields
DTIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -98.69% |
| Shareholder Yield | -98.69% |
| Earnings Yield | 14.38% |
| FCF Yield | -80.56% |
Analyst Forecast
The average price target for DTIL is $39.50, which is 376.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39.50 |
| Price Target Difference | 376.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | -3.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 14, 2024. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Feb 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |